Patofysiologisk forståelse og terapeutiske muligheder ved hæmning af okulær karvækst: Pathological and therapeutic possibilities in inhibiting ocular angionesis
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
In a variety of corneal and retinal diseases, ocular ischaemia mediates vascular endothelial growth factor (VEGF) expression, which in turn causes angiogenesis and increased vascular permeability. Consequently, VEGF-inhibitory treatment has been introduced in different ocular diseases. Hypoxia-inducible factor (HIF)-1α is an upstream regulator of VEGF-A, and increased HIF-1α expression has been established in ocular animal models. Upcoming translational studies are expected to increase our understanding of the complex balance between pro- and anti-angiogenic factors in the eye.
Bidragets oversatte titel | Pathological and therapeutic possibilities in inhibiting ocular angionesis |
---|---|
Originalsprog | Dansk |
Artikelnummer | V03200178 |
Tidsskrift | Ugeskrift for Laeger |
Vol/bind | 182 |
Udgave nummer | 21 |
Antal sider | 8 |
ISSN | 0041-5782 |
Status | Udgivet - 2020 |
Links
- https://ugeskriftet.dk/files/scientific_article_files/2020-10/v03200178_web.pdf
Forlagets udgivne version
ID: 251582883